Analystreport

Marker Therapeutics, Inc. (NASDAQ: MRKR) had its price target lowered by analysts at Piper Sandler from $5.50 to $4.00.

Marker Therapeutics, Inc.  (MRKR) 
Last marker therapeutics, inc. earnings: 11/12 04:01 pm Check Earnings Report